Contact Us

MDCG 2022-8: Application of IVDR to Legacy Devices

As most IVD manufacturers will know, a derogation to the IVDR was passed earlier this year which allows for a stepped transition in accordance with Article 110(3) of the IVDR. This allows for General IVDs registered under the IVD Directive which will require Notified Body intervention under the Regulation an extended transition period. However, there are some terms and conditions to consider, these being the Regulation requirements on:

  • Post-Market Surveillance.
  • Market Surveillance.
  • Registration of Economic Operators and Devices.

However, there is some confusion on which other requirements will apply to these legacy devices. MDCG 2022-8 aims to dispel these doubts. Here we provide an excerpt from the guidance on the applicable requirements to legacy devices:

IVDR Requirement Application to IVD Legacy Devices
Art. 10(9), (11)-(14) – manufacturers’ obligations YES (nota bene: ‘conformity with the requirements of this Regulation’ for ‘IVD legacy devices’ means conformity with the IVDD and the additional requirements in accordance with Article 110(3) IVDR)
Art. 11(3)(c)-(g), (7) – authorised representatives YES (nota bene: ‘conformity with the requirements of this Regulation’ for ‘legacy devices’ means conformity with the IVDD and the additional requirements in accordance with Article 110(3) IVDR)
Art. 13(2), 2nd subparagraph, (4), (6)-(8), (10) – importers obligations YES (nota bene: ‘conformity with the requirements of this Regulation’ for ‘IVD legacy devices’ means conformity with the IVDD and the additional requirements in accordance with Article 110(3) IVDR)
Art. 14(2), last subparagraph, (4)-(6) – distributors’ obligations YES (nota bene: ‘conformity with the requirements of this Regulation’ for ‘IVD legacy devices’ means conformity with the IVDD and the additional requirements in accordance with Article 110(3) IVDR)
Art. 15 – person responsible for regulatory compliance NO
Art. 16(3) and (4) – repackaging and relabelling NO
Art. 22 – identification in the supply chain NO (without prejudice to traceability requirements in the supply chain applicable to ‘IVD legacy devices’ in accordance with other rules such as on market surveillance of goods or the General Product Safety Directive)
Art. 24 – UDI NO (See in this respect also MDCG 2019-5 on registration of legacy devices in Eudamed)
Art. 26 – registration of devices In principle YES, but in the absence of EUDAMED’s full functionality, specific transitional provisions apply in accordance with Art. 112, 113(3)(f) IVDR
Art. 28 – registration of economic operators In principle YES, but in the absence of EUDAMED’s full functionality, specific transitional provisions apply in accordance with Art. 112, 113(3)(f) IVDR
Art. 29 – summary of safety and performance NO
Art. 78, 79 – PMS system and PMS plan YES (including PMPF according to Annex XIII Part B; however with exception of requirements that relate to non-applicable obligations, e.g. Art. 78(3)(d) – Summary of safety and performance; no requirement for a full revision of the technical documentation in accordance with Annexes II and III)
Art. 80 – PMS report YES, applicable to all ‘legacy devices’, unless manufacturer voluntarily prepares a PSUR pursuant to Article 81
Art. 81 – PSUR NO
Art. 82 – reporting of serious incidents YES
Art. 83 – trend reporting YES (trend reporting was already part of the vigilance system established under the IVDD)
Art. 84 – analysis of serious incidents and FSCA YES
Art. 85 – analysis of vigilance data YES
Art. 86 – implementing acts YES
Art. 87 – EUDAMED vigilance module In principle YES, but in the absence of EUDAMED’s full functionality, specific transitional provisions apply in accordance with Art. 112, 113(3)(f) IVDR
Art. 88 – market surveillance activities YES
Art. 89 – evaluation of non-compliances YES (nota bene: ‘conformity with the requirements of this Regulation’ for ‘legacy devices’ means conformity with the IVDD and the additional requirements in accordance with Article 110(3) IVDR)
Art. 90, 91, 92 – devices presenting an unacceptable risk; evaluation of national measures; other non-compliance YES (nota bene: ‘conformity with the requirements of this Regulation’ for ‘legacy devices’ means conformity with the IVDD and the additional requirements in accordance with Article 110(3) IVDR)
Art. 93 – preventive health protection measures YES
Art. 94 – good administrative practice YES
Art. 95 – EUDAMED market surveillance module YES

MDCG 2022-8

Advena.mt Logo Website
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.